Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Total Current Liabilities of $294.3 million for Q4 2025, down 24.13% year-on-year from $387.9 million in Q4 2024, and down 24.13% on a QoQ basis from $387.9 million in Q4 2024.

Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Total Current Liabilities for 7 consecutive years, with $294.3 million the latest figure, recorded in Q4 2025.

  • Quarterly Total Current Liabilities fell 24.13% year-over-year to $294.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $294.3 million (down 24.13% YoY) and the FY2025 annual result came in at $294.3 million, down 24.13% from the prior year.
  • Total Current Liabilities retreated to $294.3 million in Q4 2025 per CURLF's latest filing, from $387.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CURLF reached as high as $436.8 billion in Q1 2022 and fell as low as $215.3 million in Q2 2021.
  • A 5-year average of $29.5 billion and a median of $387.9 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities soared 183454.65% — and 2024, when it sank 31.81%.
  • Year by year, Total Current Liabilities stood at $316.2 million in 2021, then surged by 57.12% to $496.9 million in 2022, then slipped by 0.57% to $494.0 million in 2023, then dropped by 21.48% to $387.9 million in 2024, then dropped by 24.13% to $294.3 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $294.3 million, $387.9 million, and $379.3 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 294.31 Mn
Dec 31, 2024 387.93 Mn
Sep 30, 2024 379.26 Mn
Jun 30, 2024 392.51 Mn
Dec 31, 2023 494.03 Mn
Sep 30, 2023 556.21 Mn
Jun 30, 2023 515.88 Mn
Dec 31, 2022 496.87 Mn
Sep 30, 2022 436.92 Mn
Jun 30, 2022 382.65 Mn
Mar 31, 2022 436.81 Bn
Dec 31, 2021 316.24 Mn
Sep 30, 2021 335.21 Mn
Jun 30, 2021 215.35 Mn
Mar 31, 2021 237.97 Mn
Dec 31, 2020 220.13 Mn
Sep 30, 2020 177.15 Mn
Dec 31, 2019 106.26 Mn